Enovis (ENOV) Return on Capital Employed (2011 - 2026)
Enovis' (ENOV) quarterly Return on Capital Employed came in at 33.21% in Q2 2026, down 1498.0% year-on-year from 2.38% in Q2 2025, and down 4.44% on a QoQ basis from 31.8% in Q4 2025.
Enovis (ENOV) Return on Capital Employed (2011 - 2026) Analysis & Trends
Enovis (ENOV) has 16 years of Return on Capital Employed data on file, last reported at 33.21% in Q2 2026.
- On a quarterly basis, Return on Capital Employed fell 1498.0% year-over-year to 33.21% in Q2 2026; TTM through Apr 2026 was 33.21%, a 1498.0% decrease from a year earlier, with the FY2025 full-year figure at 30.56%, down 1157.0% from the prior year.
- Return on Capital Employed for Q2 2026 stood at 33.21%, down from 31.8% in the prior quarter.
- Over the last five years, Return on Capital Employed for ENOV reached as high as 1.61% in Q4 2023 and fell as low as 33.21% in Q2 2026.
- Historically, Return on Capital Employed has averaged 10.02% across 5 years, with a median of 2.17% in 2023.
- Across the five-year window, Return on Capital Employed jumped 41 bps in 2023 and tumbled 2864 bps in 2025, its largest moves.
- Year by year, Return on Capital Employed stood at 1.88% in 2022, then climbed by 14 bps to 1.61% in 2023, then tumbled by 947 bps to 16.84% in 2024, then slumped by 89 bps to 31.8% in 2025, then slipped by 4 bps to 33.21% in 2026.
- Per Business Quant data, the three most recent Return on Capital Employed figures were 33.21% in Q2 2026, 31.8% in Q4 2025, and 30.99% in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 11.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 24.24% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.38% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 9.30% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Enovis | 1.50 Bn | 1.47 Bn | 365.49 Mn | -33.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -33.21% |
| Dec 31, 2025 | -31.80% |
| Oct 3, 2025 | -30.99% |
| Jul 4, 2025 | -17.35% |
| Apr 4, 2025 | -18.23% |
| Dec 31, 2024 | -16.84% |
| Sep 27, 2024 | -2.35% |
| Jun 28, 2024 | -2.13% |
| Mar 29, 2024 | -1.70% |
| Dec 31, 2023 | -1.61% |
| Sep 29, 2023 | -2.17% |
| Jun 30, 2023 | -2.13% |
| Mar 31, 2023 | -1.66% |
| Dec 31, 2022 | -1.88% |
| Sep 30, 2022 | -1.69% |
| Jul 1, 2022 | -2.54% |
| Apr 1, 2022 | -2.03% |
| Dec 31, 2021 | 0.23% |
| Oct 1, 2021 | -1.99% |
| Jul 2, 2021 | -0.83% |